EBS
Emergent Biosolutions, Inc.
stockNYSE
At CloseNov 13, 2026 3:59:58 PM EST
5.78USD-1.783%(-0.11)787,173
After-hoursNov 13, 2026 4:10:30 PM EST
5.79USD+0.086%(+0.00)
EBS Financials
In Q3 FY 2026 (ended ), Emergent Biosolutions, Inc. (EBS) reported revenue of $110M, net income of −$32.7M, operating cash flow of $100.1M, and assets of $995.2M (filed ).
Loading financial flows…